Therapeutic support protocol for patient with dysosmia with or without dysgeusia related to the SARS-CoV2 virus infection
Keywords:
dysosmia, dysgeusia, Hyposmia, anosmia, covid-19, therapy, coronavirus, ORL, otolaryngologyAbstract
.
References
Jerome R. Lechien, Carlos M. Chiesa-Estomba, Daniele R. De Siati, et all.; Olfactory and gustatory dysfunction as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter european study; Eur Arch Otorhinolaryngol. 2020 Apr 6:1-11.
Klopfenstein T., Kadiane-Oussou N.J., Toko L., et all.; Features of anosmia in COVID-19; Med Mal Infect. 2020 Apr 17:S0399-077X(20)30110-4
Yan C.H., Faraji F., Prajapati D.P., et all.; Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms; Int Forum Allergy Rhinol. 2020 Apr 12:10.1002/alr.22579.
Voutilainen A., Pitkäaho T., Kvist T., et all.; How to ask about patient satisfaction? The visual analogue scale is less vulnerable to confounding factors and ceiling effect than a symmetric Likert scale; J Adv Nurs. 2016 Apr;72(4):946-57.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.